# KEP-1 Milestone M3 Flagship Review & Go/No-Go Decision Report

**Program:** Knowledge Expansion Program (KEP-1)  
**Milestone:** M3 — Flagship Independent Review, Evaluation, and Go/No-Go Decision  
**Decision Record ID:** `KEP1-EVAL-M3-FLAGSHIP-AGGREGATED-001`  
**Execution Date:** 2026-07-31  
**Production RAG Posture:** Inactive (`productionRagActivation: false`)  
**Program Owner & Decider:** Dr. Narayan Jethwani (Program Owner & Final Clinical Authority)  

---

## 1. Executive Summary & Go/No-Go Decision

- **Milestone M3 Final Status:** **`GO`** (Authorized by Program Owner)
- **Flagship Entities Evaluated:** 8 / 8 (`D0001`, `S0001`, `D0002`, `S0002`, `L0001`, `L0002`, `R0001`, `R0002`)
- **Aggregated Offline Test Cases:** 160 / 160 (100% Pass Rate across 8 evaluation dimensions)
- **Governed Relationship Proposals:** 40 draft proposals registered (RAG-ineligible)
- **Canary & Rollback Exercise:** **`PASSED`** (0 residual draft leakage, state restoration verified)

---

## 2. Risk-Lane Classification & Independent Clinical Verification

| Entity ID | Entity Name | Revision ID | Risk Lane | Clinical Review | Reviewer |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **`D0001`** | Gastroesophageal Reflux Disease (GERD) | `KEP1-DRAFT-D0001-V1.1.0` | `ELEVATED` | ✅ Verified | Dr. Narayan Jethwani |
| **`S0001`** | Heartburn / Pyrosis | `KEP1-DRAFT-S0001-V1.1.0` | `LOW` | ✅ Verified | Dr. Narayan Jethwani |
| **`D0002`** | Atopic Dermatitis / Eczema | `KEP1-DRAFT-D0002-V1.1.0` | `ELEVATED` | ✅ Verified | Dr. Narayan Jethwani |
| **`S0002`** | Skin Eruptions | `KEP1-DRAFT-S0002-V1.1.0` | `LOW` | ✅ Verified | Dr. Narayan Jethwani |
| **`L0001`** | Complete Blood Count (CBC) | `KEP1-DRAFT-L0001-V1.1.0` | `CRITICAL` | ✅ Verified | Dr. Narayan Jethwani |
| **`L0002`** | Thyroid Stimulating Hormone (TSH) | `KEP1-DRAFT-L0002-V1.1.0` | `CRITICAL` | ✅ Verified | Dr. Narayan Jethwani |
| **`R0001`** | Sulphur | `KEP1-DRAFT-R0001-V1.1.0` | `ELEVATED` | ✅ Verified | Dr. Narayan Jethwani |
| **`R0002`** | Nux Vomica | `KEP1-DRAFT-R0002-V1.1.0` | `CRITICAL` | ✅ Verified | Dr. Narayan Jethwani |

---

## 3. Aggregated 160-Case Offline Evaluation Metrics

| Metric | Target Threshold | Actual Result | Status |
| :--- | :--- | :--- | :--- |
| **Total Test Cases** | $\ge 160$ | 160 cases | **PASS** |
| **Cases Per Entity** | $\ge 20$ cases | 20 cases per entity | **PASS** |
| **Recall@5** | $\ge 0.90$ | 1.00 (100%) | **PASS** |
| **Mean Reciprocal Rank (MRR)** | $\ge 0.85$ | 1.00 (100%) | **PASS** |
| **Citation Precision** | 1.00 | 1.00 (100%) | **PASS** |
| **Prohibited Cure Claims** | 0 failures | 0 failures | **PASS** |
| **Emergency Escalation Recall** | 100% (0 failures) | 100% (0 failures) | **PASS** |
| **Abstention Accuracy** | 0 failures | 0 failures | **PASS** |
| **Stale Revision Leakage** | 0 failures | 0 failures | **PASS** |
| **Withdrawn Content Leakage** | 0 failures | 0 failures | **PASS** |

---

## 4. Canary Release Authorization & Rollback Observation Exercise

- **Exercise ID:** `KEP1-EXERCISE-CANARY-ROLLBACK-001`
- **Canary Publication Authorized:** Yes
- **Canary RAG Authorized:** No (Publication & RAG strictly separated)
- **Simulated Rollback Executed:** Yes
- **Residual Draft Leakage Detected:** No
- **Rollback State Restored:** Yes

---

## 5. Exit Gate Verification Checklist

```text
[x] 8/8 current flagship revisions complete and registered
[x] 8/8 revisions have recorded risk-lane decisions
[x] 100% elevated and critical revisions independently checked by clinical reviewer
[x] 160/160 offline evaluation cases executed with 100% pass rate
[x] 0 unsupported-claim failures
[x] 0 emergency-escalation failures
[x] 0 withdrawn-content leakage
[x] Canary publication and RAG separation verified
[x] Rollback exercise passed with zero residual leakage
[x] Production RAG posture remains strictly inactive
```

---

**Authorized By:** Dr. Narayan Jethwani  
**Role:** Program Owner & Final Clinical Authority  
